-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H1Yx2wQ0sD7VCdTXKO3AJbDaChuzuVEC22PrMW4d3y0Lwwg872MpGywDvIstUjZO AGP2HMtsBOqsTojcBPyDoQ== 0001230295-07-000788.txt : 20071219 0001230295-07-000788.hdr.sgml : 20071219 20071219180606 ACCESSION NUMBER: 0001230295-07-000788 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071218 FILED AS OF DATE: 20071219 DATE AS OF CHANGE: 20071219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lamm Robert CENTRAL INDEX KEY: 0001354440 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 071317325 BUSINESS ADDRESS: BUSINESS PHONE: 732-418-9300 MAIL ADDRESS: STREET 1: C/O SAVIENT PHARMACEUTICALS, INC. STREET 2: ONE TOWER CENTER BLVD., 14TH FLOOR CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 4 1 lam273.xml X0202 4 2007-12-18 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001354440 Lamm Robert C/O SAVIENT PHARMACEUTICALS, INC ONE TOWER CENTER BLVD., 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 SVP, Quality & Reg Affairs Common Stock, $.01 par value per share 2007-12-18 4 M 0 5000 4.6700 A 47418 D Common Stock, $.01 par value per share 2007-12-18 4 S 0 5000 20.1039 D 42418 D Option to Purchase Common Stock, $.01 par value 4.6700 2007-12-18 4 M 0 5000 4.6700 D 2003-06-10 2012-06-10 Common Stock, $.01 par value per share 5000 5000 D This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934. By: /s/ Irina Azer as Attorney-In-Fact for 2007-12-19 -----END PRIVACY-ENHANCED MESSAGE-----